EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peripheral T-Cell Reprogramming Characterized by Actin Remodeling and Suppressive Communication in Pembrolizumab-Resistant Lung Adenocarcinoma

Wumiti Xiefukaiti, Aerzu Mijiti, Zi-Hang Wang, Meng-Jia Li, Qing-Mei Zhu, Nadira Dolkun, Lu-Feng Cheng, Xue-Jun Xiao

International Journal of Molecular Sciences · 19.11.2026 · 27 (22) · 10410

DOI: 10.3390/ijms272210410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.11.2026. Verfasst von Wumiti Xiefukaiti und 7 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Xinjiang Uygur Autonomous Region, Xinjiang Medical University, Key Research and Development Program of Xinjiang Uygur Autonomous Region.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistance to PD-1 blockade remains a major challenge in lung adenocarcinoma, and the systemic immune mechanisms underlying therapeutic failure are not fully understood. Peripheral blood provides a minimally invasive window to monitor immune remodeling; however, single-cell-level characterization of T-cell alterations associated with pembrolizumab resistance is still limited. Peripheral blood samples from lung adenocarcinoma patients treated with pembrolizumab were collected and stratified into response (CR/PR, n = 3) and nonresponse (SD/PD, n = 4) groups according to RECIST 1.1. Single-cell RNA sequencing was performed to profile immune cell composition and transcriptional states. hdWGCNA was applied to identify response-associated co-expression modules, CellChat was used to intercellular communication, and Monocle2 was employed to explore inferred T-cell state relationships. A total of 91,576 high-quality cells were analyzed. In pooled summaries, patients in the nonresponse group showed a higher relative proportion of CD4+ Treg cells and a lower relative proportion of CD8+ naïve T cells. Network analysis identified 23 module-related DEGs enriched in cytoskeleton- and adhesion-related functional categories. Cell–cell communication analysis predicted increased communication potential, including TGF-β and MIF pathways, and increased adhesion-type interactions such as ADGRE5–CD55 and ITGB2–ICAM1. Pseudotime analysis showed variation in cytoskeleton-associated gene expression (ACTB, ACTG1, PFN1, and S100A family genes) along the inferred trajectory, indicating variation in cytoskeleton-related transcriptional states. These findings associate pembrolizumab nonresponse with altered peripheral T-cell composition, cytoskeleton- and adhesion-related transcriptional programs, and predicted intercellular interactions, generating hypotheses for future functional and clinical validation.

Förderung

  • Natural Science Foundation of Xinjiang Uygur Autonomous Region
  • Xinjiang Medical University
  • Key Research and Development Program of Xinjiang Uygur Autonomous Region

Zitieren

APA

Xiefukaiti, W., Mijiti, A., Wang, Z., Li, M., Zhu, Q., Dolkun, N., Cheng, L., & Xiao, X. (2026). Peripheral T-Cell Reprogramming Characterized by Actin Remodeling and Suppressive Communication in Pembrolizumab-Resistant Lung Adenocarcinoma. International Journal of Molecular Sciences, 27(22), 10410. https://doi.org/10.3390/ijms272210410

Vancouver

Xiefukaiti W, Mijiti A, Wang Z, Li M, Zhu Q, Dolkun N, et al. Peripheral T-Cell Reprogramming Characterized by Actin Remodeling and Suppressive Communication in Pembrolizumab-Resistant Lung Adenocarcinoma. International Journal of Molecular Sciences. 2026;27(22):10410. doi:10.3390/ijms272210410

BibTeX
@article{Xiefukaiti2026,
  author = {Xiefukaiti, Wumiti and Mijiti, Aerzu and Wang, Zi-Hang and Li, Meng-Jia and Zhu, Qing-Mei and Dolkun, Nadira and Cheng, Lu-Feng and Xiao, Xue-Jun},
  title = {Peripheral T-Cell Reprogramming Characterized by Actin Remodeling and Suppressive Communication in Pembrolizumab-Resistant Lung Adenocarcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {22},
  pages = {10410},
  doi = {10.3390/ijms272210410}
}
Kostenlos starten →